FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38380411000001103: Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1485281000001115 Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1485291000001118 Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Is a Deoxycholic acid 20mg/2ml solution for injection vials true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Is a Belkyra true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Has specific active ingredient Deoxycholic acid true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) 4 vial Has AMP True Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start